Search results
Researchers determine timing is key for type 2 diabetes drug performance
Medical Xpress· 3 hours agoDr. Cong Xie postdoctoral research fellow in the Centre of Research Excellence in Translating Nutritional Science to Good Health, at Adelaide Medical School, worked with Associate Professor ...
How Long Should I Stay on Ozempic For Weight Loss?
MediaFeed via AOL· 2 hours agoYou know Ozempic can help with weight loss, but how long can you stay on Ozempic exactly? Unfortunately, there isn’t a solid answer to this question yet.
What's the Difference Between Ozempic and Metformin, and Which One Is Right for You?
Parade via Yahoo News· 1 day agoHowever, another drug designed to assist with type 2 diabetes treatment, metformin, had a 13-year...
This Pharma Stock Dropped 60% Premarket As FDA Halted Diabetes Drug Trials - Biomea Fusion...
Benzinga· 9 hours agoWhat Happened: The FDA’s decision was driven by concerns over potential drug-induced hepatotoxicity...
Diabetes biotech stock tanks as FDA imposes full clinical hold
FierceBiotech· 7 hours agodiabetes program over liver toxicity concerns. In preclinical tests, the molecule improved beta cell...
Weight loss medication complete guide: From Wegovy to Mounjaro
The Telegraph via Yahoo News· 2 days agoThe new generation of weight-loss drugs were initially developed to treat diabetes and work by...
Democrats ramp up patent fight with drug industry in bid to lower prices
Washington Post· 4 hours agoPramila Jayapal (D-Wash.) this week wrote to eight pharmaceutical company CEOs, urging them to...
Oral semaglutide could also help treat diabetes, cardiovascular issues
Medical News Today· 2 days agoA new clinical trial in Italy investigates the efficacy of oral semaglutide. Semaglutide and other...
New therapeutic targets to fight type 2 diabetes
Medical Xpress· 2 hours agoIt also helps to identify new drug targets in the fight against type 2 diabetes mellitus, which the World Health Organization (WHO) considers one of the ...
Biomea Fusion Crashes 67% After FDA Puts Diabetes Treatment Studies On Hold
Investor's Business Daily· 6 hours agoThe drug, BMF-291, was in early-stage testing for patients with type 1 and type 2 diabetes. The FDA...